Cargando…
Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered
To attain effective and safe pharmacotherapy, formulations in (pre)term neonates should enable extensive dose flexibility. During product development and subsequent authorization and clinical use of such formulations, there is also a need for informed decisions on excipient exposure: in addition to...
Autores principales: | Valeur, Kristine Svinning, Holst, Helle, Allegaert, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105181/ https://www.ncbi.nlm.nih.gov/pubmed/30174435 http://dx.doi.org/10.1007/s40290-018-0243-9 |
Ejemplares similares
-
Challenges and Opportunities for the Traceability of (Biological) Medicinal Products
por: Klein, Kevin, et al.
Publicado: (2018) -
Evaluation of Drug Prescribing Habits in a Postgraduate Teaching Set-up in Saudi Arabia
por: AI-Dawood, Kasim
Publicado: (1995) -
Significance of pharmaceutical excipients in prescribed medicines: a case report
por: Maharaj, Sandeep, et al.
Publicado: (2014) -
Hospitalised neonates in Estonia commonly receive potentially harmful excipients
por: Lass, Jana, et al.
Publicado: (2012) -
Editorial: Precision Medicine in Neonates
por: Allegaert, Karel, et al.
Publicado: (2021)